Latest KFF Health News Stories
Más de 100 millones de estadounidenses viven acosados por las deudas médicas
La investigación revela un problema mucho más extendido de lo que se había informado anteriormente. Esto se debe a que gran parte de la deuda que acumulan los pacientes figura como saldos de tarjetas de crédito, préstamos familiares o planes de pago a hospitales y otros proveedores médicos.
Double Shifts, Credit Card Debt, and Family Loans When Twins Were Born Early
One Chicago woman gave birth to twins 10 weeks prematurely, and the children needed extensive care. The medical bills topped out at around $80,000. Desperate, the parents loaded up credit cards, borrowed from relatives, and delayed repaying student loans.
100 Million People in America Are Saddled With Health Care Debt
The U.S. health system now produces debt on a mass scale, a new investigation shows. Patients face gut-wrenching sacrifices.
Upended: How Medical Debt Changed Their Lives
People talk about the sacrifices they made when health care forced them into debt.
Five Quick Takeaways From a Yearlong Investigation of Medical Debt in America
Today, debt from medical and dental bills touches nearly every corner of American society.
Buy and Bust: When Private Equity Comes for Rural Hospitals
Noble Health swept into two small Missouri towns promising to save their hospitals. Instead, workers and vendors say it stopped paying bills and government inspectors found it put patients at risk. Within two years — after taking millions in federal covid relief and big administrative fees — it locked the doors.
Tras Uvalde, cirujanos de trauma detallan los horrores de las masacres, y reclaman cambios
En estos años, la profesión médica ha desarrollado técnicas como la rápida evacuación de pacientes para salvar a un mayor número de víctimas de tiroteos. Pero traumatólogos cirujanos entrevistados por KHN dicen que incluso esas mejoras solo pueden salvar a una fracción de los pacientes cuando son heridas infligidas por rifles de tipo militar.
Trauma Surgeons Detail the Horror of Mass Shootings in the Wake of Uvalde and Call for Reforms
Trauma surgeons say that the weapons used in mass shootings are not new but that more of these especially deadly guns are on the street, causing injuries that are difficult to survive.
KHN’s ‘What the Health?’: Taking a Shot at Gun Control
The U.S. House passed a package of bills seeking to keep some guns out of the hands of children and teenagers, but its fate in the Senate remains a big question mark. Meanwhile, the Federal Trade Commission takes on drug and hospital prices. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Cori Uccello of the American Academy of Actuaries about the most recent report from Medicare’s trustees board.
Lawmaker Takes on Insurance Companies and Gets Personal About His Health
State Sen. Scott Wiener opens up about a weeklong stint in the hospital last year and what it’s like to live with Crohn’s disease. The San Francisco Democrat is pushing a bill that would require insurance companies to cover certain medications while patients appeal denials.
California quiere producir su propia insulina para bajar su alto costo, ¿lo conseguirá?
La administración del gobernador Gavin Newsom señaló que aproximadamente 4 millones de californianos han sido diagnosticados con diabetes, una enfermedad que puede destruir órganos, la vista y llevar a amputaciones si no se controla. La meta es prevenirlo con insulina más económica.
Misinformation Clouds America’s Most Popular Emergency Contraception
At a moment when half of U.S. states stand poised to outlaw or sharply curtail abortion services, the nation’s most popular emergency contraception brand rests in the unlikely stewardship of two private equity firms.
California Wants to Slash Insulin Prices by Becoming a Drugmaker. Can It Succeed?
Gov. Gavin Newsom proposed spending $100 million to make insulin affordable to millions of people with diabetes under a new state generic drug label, CalRx. But state officials haven’t said how much the insulin will cost patients or how the state will deal with distribution and other challenges.
With its latest venture into primary care clinics, is America’s leading organization for seniors selling its trusted seal of approval?
Despite a First-Ever ‘Right-to-Repair’ Law, There’s No Easy Fix for Wheelchair Users
Colorado lawmakers approved a measure that will make it easier for people to fix their power wheelchairs when they wear out or break down, but arcane regulations and manufacturers create high hurdles for nationwide reform.
Montana Hires a Medicaid Director With a Managed-Care Past
Montana, one of about a dozen states still managing its own Medicaid programs, has a new Medicaid director who championed handing the management of the program to private companies in Iowa and Kansas.
Agotados por covid y por trabajar 80 horas a la semana, médicos residentes deciden sindicalizarse
Los residentes son médicos recién recibidos, que han terminado la carrera de medicina, y deben pasar de tres a siete años de formación en hospitales universitarios antes de poder ejercer de forma independiente. Ganan poco y trabajan mucho.
Burned Out by Covid and 80-Hour Workweeks, Resident Physicians Unionize
In California and beyond, physician trainees working long hours for what in some states amounts to little more than minimum wage are organizing to seek better pay, benefits, and working conditions. More than 1,300 of them at three L.A. County public hospitals will vote May 30 on whether to strike.
‘An Arm and a Leg’: Private Equity Is Everywhere in Health Care. Really.
Private equity companies are the house-flippers of the investment world, and they’ve found their way into many areas of our lives — including your local gastroenterologist’s office.
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
After years of failure, the Maryland company aims to attract the vaccine-hesitant with an alternative to mRNA shots. But will it find a market?
